US FDA reports new steps in drug safety

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1138卷 / 1期

关键词：

Veteran Affair; Medical Device; Medical Product; Comprehensive Approach; Strong Interagency;

D O I：

10.2165/00128415-200711380-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[21] Anaphylactoid reactions to dextran 40 and 70: Reports to the US Food and Drug Administration (FDA)
Zinderman, Craig E.
Landow, Laurence Landow
Wise, Robert P.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S115 - S116
[22] FDA outlines steps for individualized drug development
Asher Mullard
Nature Reviews Drug Discovery, 2021, 20 : 91 - 91
[23] FDA outlines steps for individualized drug development
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (02) : 91 - 91
[24] Conducting a US FDA CVM Animal Drug Safety Study in a GLP Environment
Early, R.
McPherson, S.
Zhou, B.
Salminen, W.
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2019, 38 (01) : 46 - 47
[25] US Food and Drug Administration's (FDA) safety assessment of food ingredients
Thurmond, Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[26] FDA and Postapproval Drug Safety
不详
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 25N - 25N
[27] FDA officials argue over safety of new arthritis drug
Moynihan, R
BRITISH MEDICAL JOURNAL, 2003, 326 (7389): : 565 - 565
[28] US FDA announces new rules on safety during clinical trials
不详
FUTURE MEDICINAL CHEMISTRY, 2010, 2 (11) : 1626 - 1626
[29] Oral sodium phosphates: US FDA wants new safety measures
Reactions Weekly, 2009, 1233 (1) : 1 - 1
[30] US FDA backs safety of triazolam
Reactions Weekly, 1997, 682 (1) : 2 - 2

← 1 2 3 4 5 →